JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258665

Human SIDT1 knockout A549 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SIDT1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon11.
1 Images
Sanger Sequencing - Human SIDT1 knockout A549 cell lysate (AB258665)
  • Sanger seq

Unknown

Sanger Sequencing - Human SIDT1 knockout A549 cell lysate (AB258665)

Homozygous : 1 bp insertion in exon11

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon11.

Disease

Carcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258665-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SIDT1 knockout A549 cell lysate", "number":"AB258665-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A549 cell lysate", "number":"AB258665-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SIDT1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The SID1 transmembrane family member 1 (SIDT1) protein is involved in the transport of small interfering RNA (siRNA) across cellular membranes. SIDT1 is also known as SID-1 homolog 1 or SID-1 transmembrane family member 1 and it has a mass of approximately 89 kDa. It is expressed in various tissues with notable expression in the placenta and kidney suggesting its functional significance in these locations.
Biological function summary

SIDT1 is involved in the RNA interference (RNAi) pathway which regulates gene expression. This protein is not known to form parts of larger protein complexes but serves as a channel for dsRNA molecules. SIDT1's activity can affect gene silencing processes by facilitating the entry of siRNA from the extracellular environment into the cell cytoplasm playing an important role in post-transcriptional gene regulation.

Pathways

SIDT1 plays a role in the RNA interference pathway important for post-transcriptional regulation of genes. It is associated with the machinery of RNAi which includes Dicer and Argonaute proteins. These interactions are important because they allow for precise gene expression control. SIDT1 facilitates the cellular uptake of siRNA thereby influencing gene expression levels and impacting regulatory pathways tied to cellular homeostasis.

SIDT1 has potential links to disorders involving aberrant gene expression such as certain carcinomas. Its role in enabling RNAi makes it a subject of interest in cancer research where dysregulated gene silencing mechanisms may contribute to disease. Connections between SIDT1 and other proteins like Argonaute in these disease processes provide avenues for therapeutic exploration making SIDT1 a target for interventions aiming to modulate RNAi-related pathways in cancer therapy.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com